Cargando…
Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis
BACKGROUND: Some studies have found that hypomagnesemia is associated with vascular calcification, atherosclerosis, and cardiovascular disease, which may lead to increased mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) who need to maintain hemodialysis (HD...
Autores principales: | Liu, Hongyan, Wang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589258/ https://www.ncbi.nlm.nih.gov/pubmed/34766558 http://dx.doi.org/10.1097/MD.0000000000027486 |
Ejemplares similares
-
Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease
por: Pinnell, Derek, et al.
Publicado: (2022) -
Impact of serum albumin level and variability on short-term cardiovascular-related and all-cause mortality in patients on maintenance hemodialysis
por: Chen, Chun, et al.
Publicado: (2021) -
Renal Function and All-Cause Mortality Risk Among Cancer Patients
por: Yang, Yan, et al.
Publicado: (2016) -
Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease
por: Chang, Po-Ya, et al.
Publicado: (2015) -
Serum level of high mobility group box protein-1 and prognosis of patients with end-stage renal disease on hemodialysis and peritoneal dialysis
por: Chen, Linyan, et al.
Publicado: (2021)